EndParalysis first financial contribution to spinal cord injury research.
EINDHOVEN (The Netherlands) – April 17, 2015
The endParalysis Foundation (www.endparalysis.org) announces a donation of €25.000 as a contribution to facilitate the promising “Chondroitinase” therapy and make it ready for clinical trials on spinal cord injury patients. The donation is accepted by Prof. Joost Verhaagen of the Netherlands Institute of Neuroscience (NIN-www.nin.nl) in Amsterdam, on behalf of Spinal Research. Spinal cord injury research for treatment / therapy / cure : endParalysis first financial contribution to advance research into curing SCI…
The Dutch NIN will carry out its research together with various laboratories in the UK. The project was initiated by the British foundation Spinal Research/ISRT (International Spinal Research Trust – www.spinal-research.org), one of the international partners of endParalysis Foundation.
A spinal cord injury has far reaching consequences for the patient. Not only is mobility under question, but also the control of all organs below the level of the lesion. The aim of this joint research project is to neutralize the scar tissue that forms in the spinal cord just after the lesion and to enable the damaged nerves to grow again thereby giving patients a chance for a certain level of functional recovery in the future.
Newly established endParalysis Foundation started raising funds in September 2014 and its primary aim is to collect €50.000 to co-finance this research. Founder and President, Corinne Jeanmaire, was therefore delighted to be handing over the first €25.000 to sponsor the project.
Find out more about the Chondroitinase (Chase-it) research project here
MoSpinal cord injury research for treatment / therapy / cure : endParalysis first financial contribution to advance research into curing SCI…